{"id":539147,"date":"2021-09-16T09:03:38","date_gmt":"2021-09-16T13:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/"},"modified":"2021-09-16T09:03:38","modified_gmt":"2021-09-16T13:03:38","slug":"briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/","title":{"rendered":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30"},"content":{"rendered":"
\n

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (\u201cBriaCell\u201d or the \u201cCompany\u201d)<\/strong>, a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at the Benzinga Healthcare Small Cap Conference, which is being held virtually on September 29-30, 2021.<\/p>\n

Dr. Bill Williams, BriaCell’s President and CEO, will deliver his corporate presentation at 1:15pm ET on September 29. \u00a0Management will be available for one-on-one meetings to be held throughout the conference. Investors can register to receive a free spectator pass for the event: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/<\/u><\/a>.<\/p>\n

\n About BriaCell Therapeutics Corp.<\/strong>\n <\/p>\n

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https:\/\/briacell.com\/<\/u><\/a>.<\/p>\n

\n Safe Harbor<\/strong>\n <\/p>\n

This press release contains \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d “will\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on BriaCell\u2019s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in the Company’s most recent Management\u2019s Discussion and Analysis, under \u201cRisks and Uncertainties\u201d in the Company’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under our profiles on SEDAR at www.sedar.com and on EDGAR at www.sec.gov<\/u><\/a><\/strong>. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.<\/p>\n

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/p>\n

\n Contact Information<\/strong>\n <\/p>\n

\n Company Contact:<\/strong>
\n
William V. Williams, MD
President & CEO
1-888-485-6340
info@briacell.com<\/u><\/a><\/p>\n

\n Media Relations:<\/strong>
\n
Jules Abraham
Director of Public Relations
CORE IR
917-885-7378
julesa@coreir.com<\/u><\/a>\u00a0<\/p>\n

\n Investor Relations Contact:<\/strong>
\n
CORE IR
investors@briacell.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (\u201cBriaCell\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at the Benzinga Healthcare Small Cap Conference, which is being held virtually on September 29-30, 2021. Dr. Bill Williams, BriaCell’s President and CEO, will deliver his corporate presentation at 1:15pm ET on September 29. \u00a0Management will be available for one-on-one meetings to be held throughout the conference. Investors can register to receive a free spectator pass for the event: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches … <\/p>\n

Continue reading “BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-539147","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (\u201cBriaCell\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at the Benzinga Healthcare Small Cap Conference, which is being held virtually on September 29-30, 2021. Dr. Bill Williams, BriaCell’s President and CEO, will deliver his corporate presentation at 1:15pm ET on September 29. \u00a0Management will be available for one-on-one meetings to be held throughout the conference. Investors can register to receive a free spectator pass for the event: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches … Continue reading "BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-16T13:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30\",\"datePublished\":\"2021-09-16T13:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/\"},\"wordCount\":445,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/\",\"name\":\"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=\",\"datePublished\":\"2021-09-16T13:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/","og_locale":"en_US","og_type":"article","og_title":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk","og_description":"BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (\u201cBriaCell\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at the Benzinga Healthcare Small Cap Conference, which is being held virtually on September 29-30, 2021. Dr. Bill Williams, BriaCell’s President and CEO, will deliver his corporate presentation at 1:15pm ET on September 29. \u00a0Management will be available for one-on-one meetings to be held throughout the conference. Investors can register to receive a free spectator pass for the event: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches … Continue reading \"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-16T13:03:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30","datePublished":"2021-09-16T13:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/"},"wordCount":445,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/","name":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=","datePublished":"2021-09-16T13:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjkzNSM0NDA4MjczIzIwOTA2NTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/briacell-to-present-at-the-benzinga-healthcare-small-cap-conference-september-29-30\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=539147"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=539147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=539147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=539147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}